Related Experiment Video
Updated: May 15, 2026

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
Myelin protein zero Arg36Gly mutation with very late onset and rapidly progressive painful neuropathy
Patrizia Dacci1, Franco Taroni, Eleonora Dalla Bella
1Neuromuscular Diseases Unit, IRCCS Foundation, ‘‘Carlo Besta’’ Neurological Institute, Via Celoria, 11, 20133 Milan, Italy.
Abstract:
Mutations in myelin protein zero (MPZ) protein result in a wide spectrum of peripheral neuropathies, from congenital hypomyelinating to late onset sensory and motor axonal forms. In some patients, neuropathic pain can be a prominent symptom, making the diagnosis challenging mainly in those with other risk factors for neuropathy. We describe a 77-year-old woman with impaired glucose tolerance presenting with rapidly progressive axonal neuropathy leading to excruciating pain and severe weakness of lower limbs within 2 years from the onset. Her son abruptly complained of similar painful symptoms at the age of 47 years. Molecular analysis revealed a novel heterozygous missense mutation (c.106A>G) in MPZ exon 2, causing the substitution of arginine-36 with glycine in the extracellular domain. Our observation suggests that MPZ-related neuropathy should be considered in the diagnostic work up of patients with painful axonal neuropathy even presenting with rapid progression and at a very late age of onset.
More Related Videos
Related Concept Videos
Multiple Sclerosis l: Introduction
Nervous Tissue: Myelin
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Diabetic Neuropathy
Myasthenia Gravis ll: Pathophysiology

